id todo:paper_00664804_v56_n10_p5315_Ciccarelli
record_format dspace
spelling todo:paper_00664804_v56_n10_p5315_Ciccarelli2023-10-03T14:53:05Z Antiparasitic effect of vitamin B12 on Trypanosoma cruzi Ciccarelli, A.B. Frank, F.M. Puente, V. Malchiodi, E.L. Batlle, A. Lombardo, M.E. ascorbate peroxidase ascorbic acid benznidazole cobalamin cyanocobalamin dithiothreitol heme hemin reactive oxygen metabolite superoxide dismutase trypanothione reductase amastigote animal experiment animal model antimicrobial activity antiparasitic activity article controlled study cytotoxicity drug mechanism enzyme activity epimastigote female growth inhibition IC 50 in vitro study in vivo study male mouse nonhuman parasitemia priority journal Trypanosoma cruzi trypomastigote Animals Chagas Disease Female Male Mice Nitroimidazoles Trypanocidal Agents Trypanosoma cruzi Vitamin B 12 A nutritional characteristic of trypanosomatid protozoa is that they need a heme compound as a growth factor. Because of the cytotoxic activity of heme and its structural similarity to cobalamins, we have investigated the in vitro and in vivo effect of vitamin B12 (or cyanocobalamin) on the different forms of Trypanosoma cruzi. Cyanocobalamin showed a marked antiparasitic activity against epimastigotes (50% inhibitory concentration [IC50], 2.42 μM), amastigotes (IC50, 10.69 μM), and trypomastigotes (IC50, 9.46 μM). Anti-epimastigote and -trypomastigote values were 1.7 to 4 times lower than those obtained with the reference drug benznidazole (Bnz). We also found that B12 and hemin do not interact with each other in their modes of action. Our results show that B12 increases intracellular oxidative activity and stimulates both superoxide dismutase (50%) and ascorbate peroxidase (20%) activities, while the activity of trypanothione reductase was not modified. In addition, we found that the antioxidants dithiothreitol and ascorbic acid increase the susceptibility of the parasite to the cytotoxic action of B12. We propose that vitamin B12 exerts its growth-inhibitory effect through the generation of reactive oxygen species. In an in vivo assay, a significant reduction in the number of circulating parasites was found in T. cruzi-infected mice treated with cyanocobalamin and ascorbic acid. The reduction of parasitemia in benznidazole-treated mice was improved by the addition of these vitamins. According to our results, a combination of B12 and Bnz should be further investigated due to its potential as a new therapeutic modality for the treatment of Chagas' disease. Copyright © 2012, American Society for Microbiology. All Rights Reserved. Fil:Ciccarelli, A.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Batlle, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Lombardo, M.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00664804_v56_n10_p5315_Ciccarelli
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic ascorbate peroxidase
ascorbic acid
benznidazole
cobalamin
cyanocobalamin
dithiothreitol
heme
hemin
reactive oxygen metabolite
superoxide dismutase
trypanothione reductase
amastigote
animal experiment
animal model
antimicrobial activity
antiparasitic activity
article
controlled study
cytotoxicity
drug mechanism
enzyme activity
epimastigote
female
growth inhibition
IC 50
in vitro study
in vivo study
male
mouse
nonhuman
parasitemia
priority journal
Trypanosoma cruzi
trypomastigote
Animals
Chagas Disease
Female
Male
Mice
Nitroimidazoles
Trypanocidal Agents
Trypanosoma cruzi
Vitamin B 12
spellingShingle ascorbate peroxidase
ascorbic acid
benznidazole
cobalamin
cyanocobalamin
dithiothreitol
heme
hemin
reactive oxygen metabolite
superoxide dismutase
trypanothione reductase
amastigote
animal experiment
animal model
antimicrobial activity
antiparasitic activity
article
controlled study
cytotoxicity
drug mechanism
enzyme activity
epimastigote
female
growth inhibition
IC 50
in vitro study
in vivo study
male
mouse
nonhuman
parasitemia
priority journal
Trypanosoma cruzi
trypomastigote
Animals
Chagas Disease
Female
Male
Mice
Nitroimidazoles
Trypanocidal Agents
Trypanosoma cruzi
Vitamin B 12
Ciccarelli, A.B.
Frank, F.M.
Puente, V.
Malchiodi, E.L.
Batlle, A.
Lombardo, M.E.
Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
topic_facet ascorbate peroxidase
ascorbic acid
benznidazole
cobalamin
cyanocobalamin
dithiothreitol
heme
hemin
reactive oxygen metabolite
superoxide dismutase
trypanothione reductase
amastigote
animal experiment
animal model
antimicrobial activity
antiparasitic activity
article
controlled study
cytotoxicity
drug mechanism
enzyme activity
epimastigote
female
growth inhibition
IC 50
in vitro study
in vivo study
male
mouse
nonhuman
parasitemia
priority journal
Trypanosoma cruzi
trypomastigote
Animals
Chagas Disease
Female
Male
Mice
Nitroimidazoles
Trypanocidal Agents
Trypanosoma cruzi
Vitamin B 12
description A nutritional characteristic of trypanosomatid protozoa is that they need a heme compound as a growth factor. Because of the cytotoxic activity of heme and its structural similarity to cobalamins, we have investigated the in vitro and in vivo effect of vitamin B12 (or cyanocobalamin) on the different forms of Trypanosoma cruzi. Cyanocobalamin showed a marked antiparasitic activity against epimastigotes (50% inhibitory concentration [IC50], 2.42 μM), amastigotes (IC50, 10.69 μM), and trypomastigotes (IC50, 9.46 μM). Anti-epimastigote and -trypomastigote values were 1.7 to 4 times lower than those obtained with the reference drug benznidazole (Bnz). We also found that B12 and hemin do not interact with each other in their modes of action. Our results show that B12 increases intracellular oxidative activity and stimulates both superoxide dismutase (50%) and ascorbate peroxidase (20%) activities, while the activity of trypanothione reductase was not modified. In addition, we found that the antioxidants dithiothreitol and ascorbic acid increase the susceptibility of the parasite to the cytotoxic action of B12. We propose that vitamin B12 exerts its growth-inhibitory effect through the generation of reactive oxygen species. In an in vivo assay, a significant reduction in the number of circulating parasites was found in T. cruzi-infected mice treated with cyanocobalamin and ascorbic acid. The reduction of parasitemia in benznidazole-treated mice was improved by the addition of these vitamins. According to our results, a combination of B12 and Bnz should be further investigated due to its potential as a new therapeutic modality for the treatment of Chagas' disease. Copyright © 2012, American Society for Microbiology. All Rights Reserved.
format JOUR
author Ciccarelli, A.B.
Frank, F.M.
Puente, V.
Malchiodi, E.L.
Batlle, A.
Lombardo, M.E.
author_facet Ciccarelli, A.B.
Frank, F.M.
Puente, V.
Malchiodi, E.L.
Batlle, A.
Lombardo, M.E.
author_sort Ciccarelli, A.B.
title Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
title_short Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
title_full Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
title_fullStr Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
title_full_unstemmed Antiparasitic effect of vitamin B12 on Trypanosoma cruzi
title_sort antiparasitic effect of vitamin b12 on trypanosoma cruzi
url http://hdl.handle.net/20.500.12110/paper_00664804_v56_n10_p5315_Ciccarelli
work_keys_str_mv AT ciccarelliab antiparasiticeffectofvitaminb12ontrypanosomacruzi
AT frankfm antiparasiticeffectofvitaminb12ontrypanosomacruzi
AT puentev antiparasiticeffectofvitaminb12ontrypanosomacruzi
AT malchiodiel antiparasiticeffectofvitaminb12ontrypanosomacruzi
AT batllea antiparasiticeffectofvitaminb12ontrypanosomacruzi
AT lombardome antiparasiticeffectofvitaminb12ontrypanosomacruzi
_version_ 1807321918601166848